MENLO PARK, Calif. , Aug. 02, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for its second quarter ended June 30, 2018 . Total revenue for the second quarter of 2018 was $21.6 million , compared to $20.1 million for the second

Industry Veteran Previous Served as EVP & Chief Commercial Officer of Illumina MENLO PARK, Calif. , July 31, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced

MENLO PARK, Calif. , July 23, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ:PACB) will hold its quarterly conference call to discuss its Second Quarter 2018 Financial Results on Thursday, August 2, 2018 , at 4:30pm Eastern Time .

SMRT Sequencing Chosen for Ambitious Effort to Generate Reference Genomes for 26 Maize Lines MENLO PARK, Calif. , July 10, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today

New Tools Unveiled at ASM Annual Meeting Enable Microbiologists to Do More, See More Than Ever Before MENLO PARK, Calif. , June 07, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California Inc. , (Nasdaq:PACB) today announced that obtaining microbial genomes with high accuracy and contiguity has

Gonorrhoea, Deadly Plague and Dysentery Among Collection of Bacterial Genomes Now Publicly Available Through Collaboration with Pacific Biosciences HINXTON, United Kingdom and MENLO PARK, Calif. , June 06, 2018 (GLOBE NEWSWIRE) -- The genomes of more than 3,000 bacteria, including some of the

MENLO PARK, Calif. , May 08, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leader in long-read, high-resolution sequencing, today announced that it has entered into a five-year settlement agreement with Oxford Nanopore and other parties of patent infringement

MENLO PARK, Calif. , May 02, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ:PACB) today announced financial results for its first quarter ended March 31, 2018 . Total revenue for the first quarter of 2018 was $19.4 million , compared to $24.9 million for the first quarter

MENLO PARK, Calif. , April 20, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ:PACB) will hold its quarterly conference call to discuss its First Quarter 2018 Financial Results on Wednesday, May 2, 2018 , at 4:30pm Eastern Time .

NIH-funded Program Focuses on Challenging Pediatric Cases; SMRT Sequencing Expected to Increase Solve Rate for Genetic Diagnosis MENLO PARK, Calif. , April 11, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leader in long-read, high-resolution sequencing, today